1.
PL Zinzani, L Alinari, M Tani, M Fina, S Pileri, M Baccarani. Preliminary observations of a phase II study of reduced-dose alemtuzumab treatment in patients with pretreated T-cell lymphoma. Haematologica 2005;90(5):702-703; https://doi.org/10.3324/%x.